Research at the IKC is translational and includes clinically oriented fundamental research, development of methodologies as well as clinical and epidemiological studies.
The projects of the
sphingolipids research groups are aimed to gain better understanding of cardiometabolic diseases, in particular atherosclerosis, diabetes and peripheral neuropathies, and thereby to improve diagnosis, therapy and prevention.
The biomarker research group searches and validates new candidate biomarkers for the diagnosis of cardiovascular diseases and metabolic disorders.
The IKC is also the central laboratory for several national and international
Finally, the IKC provides its broad spectrum of analytical tests and methods to many researchers, either as a service or as part of a collaboration (laboratory
analysis for research projects).